UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cell Death Regulation in Health and Disease - Part B

1, 2020

Volltextzugriff (PDF)

PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy

Journal of cellular physiology, 2019-02, Vol.234 (2), p.1313-1325

2019

Volltextzugriff (PDF)

Structure and Interactions of the Human Programmed Cell Death 1 Receptor

The Journal of biological chemistry, 2013-04, Vol.288 (17), p.11771-11785

2013

Volltextzugriff (PDF)

PD‐1/PD‐L1‐dependent immune response in colorectal cancer

Journal of cellular physiology, 2020-07, Vol.235 (7-8), p.5461-5475

2020

Volltextzugriff (PDF)

PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer

Clinical cancer research, 2017-06, Vol.23 (12), p.3158-3167

2017

Volltextzugriff (PDF)

Pore formation in regulated cell death

The EMBO journal, 2020-12, Vol.39 (23), p.e105753-n/a

2020

Volltextzugriff (PDF)

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Nature communications, 2019-04, Vol.10 (1), p.1486-17, Article 1486

2019

Volltextzugriff (PDF)

The PD-1/PD-Ls pathway and autoimmune diseases

Cellular immunology, 2014-07, Vol.290 (1), p.72-79

2014

Volltextzugriff (PDF)

Role of PD-1 during effector CD8 T cell differentiation

Proceedings of the National Academy of Sciences - PNAS, 2018-05, Vol.115 (18), p.4749-4754

2018

Volltextzugriff (PDF)

Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation

Cancer, 2017-12, Vol.123 (24), p.4823-4831

2017

Volltextzugriff (PDF)

Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis

BMC cancer, 2019-06, Vol.19 (1), p.558-558, Article 558

2019

Volltextzugriff (PDF)

Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

Advanced materials (Weinheim), 2019-04, Vol.31 (14), p.e1805888-n/a

2019

Volltextzugriff (PDF)

CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.365-377

2019

Volltextzugriff (PDF)

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

Cell biology international, 2019-06, Vol.43 (6), p.582-592

D’Arcy, Mark S

2019

Volltextzugriff (PDF)

TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients

The Journal of clinical investigation, 2015-05, Vol.125 (5), p.2046-2058

2015

Volltextzugriff (PDF)

Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine

Immunology, 2020-01, Vol.159 (1), p.75-87

2020

Volltextzugriff (PDF)

Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2

Structure (London), 2017-08, Vol.25 (8), p.1163-1174

2017

Volltextzugriff (PDF)

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

Journal of thoracic oncology, 2015-06, Vol.10 (6), p.910-923

2015

Volltextzugriff (PDF)

A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery

Proceedings of the National Academy of Sciences - PNAS, 2019-12, Vol.116 (49), p.24500-24506

2019

Volltextzugriff (PDF)

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

The New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300

2021

Volltextzugriff (PDF)

The diverse functions of the PD1 inhibitory pathway

Nature reviews. Immunology, 2018-03, Vol.18 (3), p.153-167

2018

Volltextzugriff (PDF)

Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation

Cancer cell, 2018-03, Vol.33 (3), p.480-494.e7

2018

Volltextzugriff (PDF)

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Clinical cancer research, 2014-10, Vol.20 (19), p.5064-5074

2014

Volltextzugriff (PDF)

1 – 25 von 188.231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176.570)
Mit Volltextzugriff
(166.930)

Publikationsform

9 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(185.795)
Japanisch
(34.117)
Chinesisch
(512)
Deutsch
(498)
Französisch
(371)
Russisch
(322)
Portugiesisch
(292)
Spanisch
(144)
Italienisch
(82)
Polnisch
(81)
Koreanisch
(77)
Norwegisch
(66)
Türkisch
(47)
Niederländisch
(35)
Tschechisch
(31)
Serbian
(30)
Ungarisch
(21)
Schwedisch
(15)
Dänisch
(11)
Finnisch
(7)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(161.266)
Life Sciences & Biomedicine
(141.730)
Cell Death
(102.388)
Humans
(94.536)
Animals
(69.650)
Apoptosis
(66.745)
Biological And Medical Sciences
(46.211)
Medical Sciences
(34.544)
Male
(33.055)
Mice
(31.665)
Female
(31.329)
Biochemistry & Molecular Biology
(31.031)
Proteins
(29.112)
Cell Biology
(27.698)
Oncology
(23.676)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(21.625)
Cancer
(20.950)
Cell Death - Drug Effects
(20.572)
Tumors
(18.268)
Cell Line, Tumor
(17.133)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(141.458)
EZB Free E-Journals
(105.082)
Ingenta.com
(99.675)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(63.350)
IngentaConnect Journals
(54.121)
Elsevier ScienceDirect Journals Complete
(33.221)
NUS Single-Journal Subscriptions
(27.684)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(26.373)
Wiley Online Library
(24.699)
Springer Online Journals
(23.426)
Wiley Online Library Full Collection 2018
(18.806)
Springer Nature - Connect here FIRST to enable access
(18.026)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(14.968)
Nexis Uni
(8.520)
JSTOR Complete Journals
(5.999)
Taylor & Francis Journals Auto-Holdings Collection
(5.428)
Oxford University Press Journals Current
(4.911)
Taylor & Francis
(4.424)
Taylor & Francis Online
(3.856)
SAGE Journals
(2.689)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(6.505)
International Journal Of Molecular Sciences
(3.648)
Cell Death And Differentiation
(3.212)
Scientific Reports
(2.758)
Oncogene
(2.642)
Proceedings Of The National Academy Of Sciences - Pnas
(2.031)
The Journal Of Biological Chemistry
(1.777)
Proceedings Of The National Academy Of Sciences Of The United States Of America
(1.769)
Cell Death & Disease
(1.633)
Transplantation Proceedings
(1.609)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cell Death Regulation in Health and Disease - Part B

PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy

Structure and Interactions of the Human Programmed Cell Death 1 Receptor

PD‐1/PD‐L1‐dependent immune response in colorectal cancer

PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer

Pore formation in regulated cell death

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

The PD-1/PD-Ls pathway and autoimmune diseases

Role of PD-1 during effector CD8 T cell differentiation

Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation

Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis

Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients

Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine

Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

The diverse functions of the PD1 inhibitory pathway

Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Suchergebnisse filtern